With the latest EU approval, dsm-firmenich Animal Nutrition & Health extends Hy-D® authorization to aquaculture, following its approval for pigs, poultry and ruminants.
dsm-firmenich Animal Nutrition & Health has announced that Hy-D®, 25-hydroxycholecalciferol (25-OH-D₃) produced from Saccharomyces cerevisiae CBS 146008, has received new European Union authorization for use in salmonids, other fish species, and all other animal species. Hy-D®has been authorized in the EU for pigs, poultry and ruminants since 2024.
dsm-firmenich Animal Nutrition & Health notes that this landmark decision by the European Commission means:
• Commercial Availability: Hy-D®is officially authorized for commercial use as a nutritional additive in aquaculture and all animal feed across the EU, expanding access for feed producers, integrators and farmers as of December 31, 2025.
• A First for EU Aquaculture: This is the first time 25-hydroxycholecalciferol is approved for use in salmonids and all aquatic species, marking a significant advancement for the aquaculture industry.
• Proof of Safety from a Unique Production Process: The European Food Safety Authority (EFSA) has confirmed the safety and efficacy of Hy-D® produced from Saccharomyces cerevisiae CBS 146008 for all animal species, as well as for consumers, users and the environment.
According to the statement, Hy-D®, an innovative vitamin D3 metabolite, supports optimal levels of 25-OH-D₃, providing all-round benefits in animal health and welfare, performance and productivity, and overall food quality. Proper usage of Hy-D® can positively impact animal wellbeing and productivity.
Emrah Mazi, Head of Special Nutrients at dsm-firmenich Animal Nutrition & Health said, “This new EU authorization for Hy-D® is a significant milestone, underscoring its global relevance and reliability as a source of vitamin D for aquaculture and all animal species. We are thrilled about the opportunities this brings for our customers across Europe and beyond, empowering them to advance animal health and performance with confidence.”
Dr. Benedict Standen, Head of Marketing for Aquaculture at dsm-firmenich Animal Nutrition & Health stated, “EU authorization for Hy-D® represents a first-of-its-kind opportunity to bring real benefits to European aquaculture, which have already been seen in commercial aquaculture operations around the world. These include improvements in growth, immunity and enhanced product quality.”
The company says that this milestone advances the its mission to deliver safe, effective, and sustainable nutritional solutions, marking a 25-year journey to bring the benefits of Hy-D® to all species in the European Union.
